Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -518 | -406 | -6 |
| Other Working Capital | -295 | -352 | 2 |
| Other Operating Activity | 190 | 311 | 0 |
| Operating Cash Flow | $-623 | $-447 | $-4 |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | -138,000 | -138,000 | N/A |
| Investing Cash Flow | $-138,000 | $-138,000 | $0 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 31 | 31 | N/A |
| Common Stock Issued | 140,075 | 140,075 | N/A |
| Other Financing Activity | -803 | -618 | 179 |
| Financing Cash Flow | $139,304 | $139,489 | $179 |
| Beginning Cash Position | 175 | 175 | 0 |
| End Cash Position | 856 | 1,217 | 175 |
| Net Cash Flow | $680 | $1,042 | $175 |
| Free Cash Flow | |||
| Operating Cash Flow | -623 | -447 | -4 |
| Free Cash Flow | -623 | -447 | -4 |